HK-listed gold stocks jump as US economic fears boost bullion prices
Cardlytics Inc (NASDAQ:CDLX) shares tumbled to a 52-week low of $2.44, reflecting a stark downturn for the transaction-driven marketing firm. With a market capitalization of just $124.5 million and an EBITDA of -$36.6 million in the last twelve months, the company faces significant operational challenges. According to InvestingPro analysis, the stock appears slightly undervalued at current levels, though significant risks remain. The company’s stock has faced significant headwinds over the past year, with the 1-year change data revealing a precipitous drop of -67.67% in its value. This decline underscores the challenges Cardlytics has encountered in a competitive market, with revenue declining 3% and a concerning debt-to-equity ratio of 3.18. While the company maintains a current ratio of 1.18, indicating adequate short-term liquidity, its path to recovery remains uncertain amidst investor skepticism and a rapidly evolving digital marketing landscape. For deeper insights into CDLX’s financial health and growth prospects, investors can access comprehensive analysis and 11 additional ProTips through InvestingPro’s detailed research reports.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.